<SEC-DOCUMENT>0001837607-24-000022-index.html : 20240401 <SEC-HEADER>0001837607-24-000022.hdr.sgml : 20240401 <ACCEPTANCE-DATETIME>20240401172709 ACCESSION NUMBER: 0001837607-24-000022 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 EFFECTIVENESS DATE: 20240401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AEON Biopharma, Inc. CENTRAL INDEX KEY: 0001837607 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 853940478 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-278442 FILM NUMBER: 24811173 BUSINESS ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: (949) 354-6499 MAIL ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: Priveterra Acquisition Corp. DATE OF NAME CHANGE: 20201222 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>aeon-20231109xs8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: aeon-20231109xs8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>aeon-20231109xex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: aeon-20231109xex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>aeon-20231109xex23d1.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: aeon-20231109xex23d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>4 <FILENAME>aeon-20231109xex23d2.htm <DESCRIPTION>EX-23.2 <TEXT> Document 4 - file: aeon-20231109xex23d2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.8 <SEQUENCE>5 <FILENAME>aeon-20231109xex99d8.htm <DESCRIPTION>EX-99.8 <TEXT> Document 5 - file: aeon-20231109xex99d8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>6 <FILENAME>aeon-20231109xexfilingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 6 - file: aeon-20231109xexfilingfees.htm
</DOCUMENT> </SEC-DOCUMENT>